6G4-12365-37710
2 vaccinations
2 coded responses
6 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 226 / VA
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-26
Dose 1 — Pfizer-BioNTech
-
2021-03-19
Dose 2 — Pfizer-BioNTech
-
2021-03-31
Registered in v-safe
- 2021-03-31
- 2021-04-02
- 2021-04-09
-
2021-06-18
Survey response — 3 months, dose 2MedDRA: Benign breast neoplasm, Surgery — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: I had a 3cm solid prolific breast tumor appear that had to be surgically removed. It turned out to be benign with atypia. It was on the breast opposite of the arm where I received the injection and is presumed to be unrelated. · Healthcare visit (other): SurgeryMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-18
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-06-22
- 2021-09-17
-
2022-03-20
Survey response — 12 months, dose 2MedDRA: Breast mass — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: A second breast lump in my other breast (solid, not cystic)MedDRA releases: 2024-11 · check-in free text available
-
2022-03-20
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-03-28
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-26 | Pfizer-BioNTech | |
| 2 | 2021-03-19 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-18 | Successful | Participant prefers to complete VAERS report online |
| 2022-03-20 | Successful 2022-03-28 |
Participant prefers to complete VAERS report online |
Free text
Release 9 — 3 months, dose 2
Symptoms: I had a 3cm solid prolific breast tumor appear that had to be surgically removed. It turned out to be benign with atypia. It was on the breast opposite of the arm where I received the injection and is presumed to be unrelated.
Healthcare visit (other): Surgery
Release 11 — 12 months, dose 2
Symptoms: A second breast lump in my other breast (solid, not cystic)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Surgery | ✓ | ✓ | ✓ |
| SD | Benign breast neoplasm | ✓ | ✓ | ✓ |
| SD | Breast mass | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release